Besides, Zhu and coworkers reported that miR-192-5p is an upstream regulator of thyroid hormone receptor interactor 13 (TRIP13), a promising oncogene in HCC, by directly targeting the 3′-UTR of TRIP13 mRNA, thereby inhibiting the progression of HCC (Zhu et al., 2019). The gene discussed is TRIP13; the disease is hepatocellular carcinoma.